Pfizer fights off generic pregabalin
Pfizer has won an extension to an existing injunction prohibiting the manufacture of a generic version of its painkiller Lyrica (pregabalin).
Pfizer was recently awarded an interlocutory injunction against generic manufacturer Apotex version of pregabalin for treating neuropathic pain.
Yesterday, the Federal Court extended this injunction to cover all indications.
In a statement, Pfizer said it “welcomed…. the decision to extend the interlocutory injunction previously issued against Apotex's generic